NVDA
NVIDIA
-- 142.620 TSLA
Tesla
-- 406.580 PLTR
Palantir
-- 78.980 MSTR
MicroStrategy
-- 353.670 RGTI
Rigetti Computing
-- 13.2000 
News
$Citius Pharmaceuticals (CTXR.US)$ $Citius Oncology (CTOR.US)$ Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
PR Newswire· 4 mins ago
PR Newswire· 4 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day
萬軍無兵策天鳳 : Keep in mind, it said it would commercialize in the second half of 2024 as early as the first half of 2024.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Teddy123 : About time isn't it?!